At a glance
- Originator Nordic
- Class Anti-ischaemics; Benzofurans; Neuroprotectants
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cerebral infarction; Cerebral ischaemia; Cerebrovascular disorders
Most Recent Events
- 17 Mar 1998 Preclinical development for Cerebral infarction in France (Unknown route)
- 17 Mar 1998 Preclinical development for Cerebral ischaemia in France (Unknown route)
- 17 Mar 1998 Preclinical development for Cerebrovascular disorders in France (Unknown route)